Pages
Products

AAV1-TRE-Cre

For research use only. Not intended for any clinical use.

Cat. No. :   AAV00144Z

Serotype :   AAV Serotype 1 Storage :   -80 ℃

Titer: Size:

Inquire for Price

Virus Particles Information

Quality Control

Cat. No. AAV00144Z
Description AAV serotype 1 particles contain Cre recombinase under TRE-Tight promoter and its expression can be responsive to the tTA and rtTA regulatory proteins.
Serotype AAV Serotype 1
Applications

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Summary Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

AAV has evolved into one of the most important and safest viral gene delivery vectors in the field of gene therapy. The simplicity of the AAV genome enables the design of rAAV vectors to directly deliver transgenes of interest. The inverted terminal repeats on either side of the genome are the only cis-acting elements required for genome replication, integration, and packaging into capsids. Therefore, rAAV can be produced by replacing the replication and capsid genes with a promoter and the therapeutic gene of interest (vector DNA). The rep and cap genes are expressed in trans from different plasmids lacking ITRs. The separation of these genes from the vector plasmid DNA is critical for circumventing the formation of wtAAV.

Ad and HSV have been shown to be required for rAAV replication and production. Regarding the Ad helper virus, the E1a, E1b, E2a, E4orf6, and VA RNA genes have been identified to provide the helper functions required for rAAV production.

Infecting producer cells with Ad to generate rAAV allows for efficient production of rAAV, but as a consequence it also produces Ad particles. A major improvement in the evolution of rAAV production was the introduction of the triple plasmid transfection method. This method uses AAV serotype-specific rep and cap plasmids and a vector DNA plasmid, but eliminates the use of Ad infection by providing the essential Ad genes on a third plasmid (pXX6). Providing Ad helper genes on the pXX6 plasmid eliminates Ad production in transfected cells, resulting in the production of only rAAV vector. Multi-plasmid transient transfection of adherent HEK293 cells remains the most widely used method for rAAV production.

The dorsal medial prefrontal cortex (dmPFC) plays a dual role in regulating drug-seeking and fear-related behaviors. Here, researchers explored the stability of a dmPFC cocaine-seeking assembly over 2 weeks and its effects on persistent cocaine-seeking and fear memory retrieval. In the first series of experiments, researchers trained TetTag c-fos-driven EGFP mice for cocaine self-administration and labeled neurons that were robustly activated with EGFP during an initial cocaine-seeking session on day 7. A follow-up seeking test was then performed 2 weeks later to examine assembly reactivation between seeking sessions by c-Fos immunostaining. In the second series of experiments, researchers co-injected viruses expressing TRE-cre and a cre-dependent inhibitory PSAM-GlyR into the dmPFC of male and female c-fos-tTA mice in order to "tag" cocaine-seeking or cued-fear assembly neurons with inhibitory chemogenetic receptors. The contribution of ensembles to subsequent cocaine seeking and fear recall during inhibition of labeled ensembles was then investigated by administering uPSEM792s, a selective ligand for PSAM-GlyR. In both sexes, there was a positive correlation between the persistence of cocaine seeking and the proportion of reactivated EGFP+ neurons within the dmPFC. The results suggest that cocaine and fear recall ensembles in the dmPFC are stable but largely mutually exclusive.

To test whether reactivation of the dmPFC drug-seeking ensemble is necessary for subsequent cocaine seeking, researchers used a chemogenetic ensemble tagging strategy in which c-fos-tTA mice were co-injected with AAV1-TRE-cre and cre-dependent inhibitory PSAM-GlyR (AAV-FLEX-PSAM-GlyR-EGFP) into the dmPFC (Figure 1A). A large number of neurons expressing EGFP were observed in the dmPFC of the labeled group, while negligible EGFP expression was detected in the dmPFC of the unlabeled group maintained with dox during the day 7 cocaine seeking session (Figure 1B). In addition, researchers determined the in vitro function of inhibitory PSAM-GlyR on dmPFC pyramidal neurons using whole-cell patch clamp electrophysiology (Figure 1C). Pressure injection of the PSAM-GlyR ligand uPSEM792s (50 nM) blocked action potential firing in EGFP+ neurons expressing PSAM-GlyR, but had no effect on EGFP- neurons, confirming that uPSEM792s selectively inhibits neuronal activity in cells expressing PSAM-GlyR.

Validation of expression and function of cre-dependent PSAM-GlyR.Figure 1. Validation of expression and function of cre-dependent PSAM-GlyR. (Liu S, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
User-Friendly

What stood out to me was not just the quality of the AAV1-TRE-Cre vector but also the excellent technical support and comprehensive resources provided.

United Kingdom

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction